Loveday C, Garrett A, Law P, Hanks S, et al. Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes. Ann Oncol 2022;33:1318-1327.
PMID: 36122798